Global Neurology Academy
The Global Neurology Academy (GNA) series offers certified education modules and video interviews from leading MS experts from across the globe as they address topics such as induction therapy in relapsing-remitting multiple sclerosis; No Evidence of Disease Activity (NEDA) concept; how different agents used in MS management may be utilized in induction therapy; appreciation of how reductions in end-organ damage impact patient quality-of-life; mechanisms of action of the classical as well as emergent agents; key issues associated with making the correct differential diagnosis of multiple sclerosis, in addition to how best to incorporate prognostic indicators into clinical decision-making; current and emergent novel oral agents in MS management; and diagnostic strategies and identifying predictors of outcome.
For more information about GNA, visit www.globalneurologyacademy.org.
Episodes 61-75 of 76
The Diagnostic Challenges of Spinal Cord Lesions in MS
CME/CEThe Diagnostic Challenges of Spinal Cord Lesions in MS
Therapeutic Mechanism of Action (MOAs) in MS: Targeting T- and B-cells to Reset the Immune System
Global Neurology AcademyTherapeutic Mechanism of Action (MOAs) in MS: Targeting T- and B-cells to Reset the Immune System
Benefit/Risk Strategies in Selecting Therapeutic Solutions for MS
Global Neurology AcademyBenefit/Risk Strategies in Selecting Therapeutic Solutions for MS
Multiple Sclerosis Physician Resources
Global Neurology AcademyMultiple Sclerosis Physician Resources
Highlights from the MAGNIMS Consensus Guidelines
Global Neurology AcademyHighlights from the MAGNIMS Consensus Guidelines
Establishing Partnerships to Optimize Patient Outcomes
Global Neurology AcademyEstablishing Partnerships to Optimize Patient Outcomes
Immunologic Effects on Metabolic Syndrome and MS
Global Neurology AcademyImmunologic Effects on Metabolic Syndrome and MS
Personalized Approach to Managing MS Patients - Dr. Andrew Chan
Global Neurology AcademyPersonalized Approach to Managing MS Patients - Dr. Andrew Chan
Determining an MS Patient's Long-Term Prognosis
CME/CEDetermining an MS Patient's Long-Term Prognosis
The Value of Biomarkers in MS Patients
Global Neurology AcademyThe Value of Biomarkers in MS Patients
